Health Care: Drugs

Coherus BioSciences Inc (CHRS: NASDAQ)

$15.68 n/a | n/a%
12/26/14 - 03:59 PM ET
Company Balance Sheet
Dec 2013
Assets
Cash and Equivalents 39.55M
Receivables 385.00K
Inventories 0.00
Other Current Assets 0.00
Total Current Assets 45.68M
Property, Plant & Equipment, Gross 2.37M
Accumulated Depreciation & Depletion 625.00K
Property, Plant & Equipment, Net 1.74M
Intangibles 0.00
Other Non-Current Assets 27.00K
Total Non-Current Assets 1.77M
Liabilities & Shareholder Equity
Total Assets 47.45M
Accounts Payable 3.68M
Short Term Debt 3.09M
Other Current Liabilities 24.27M
Total Current Liabilities 53.70M
Long Term Debt 0.00
Deferred Income Taxes 0.00
Other Non-Current Liabilities 36.13M
Minority Interest 0.00
Total Non-Current Liabilities 90.82M
Total Liabilities 144.52M
Preferred Stock Equity 0.00
Common Stock Equity -97.08M
Common Par 1.00K
Additional Paid In Capital 2.51M
Cumulative Translation Adjustment 0.00
Retained Earnings -99.59M
Treasury Stock 0.00
Other Equity Adjustments 0.00
Total Capitalization -97.08M
Total Equity -97.08M
Total Liabilities & Stock Equity 47.45M
Total Common Shares Outstanding 32.05M
Preferred Shares 0.00
Treasury Shares 0.00
Basic Weighted Shares Outstanding 14.69M
Diluted Weighted Shares Outstanding 14.69M
Number of Employees NA
Number of Part-Time Employees NA

Portfolios with CHRS

Latest CHRS Headlines from TheStreet

More Financial News for CHRS

Press Releases for CHRS

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter